Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Yellow Fever | 5 | 2018 | 231 | 1.09 | Why? |
| West Nile virus | 3 | 2018 | 206 | 0.93 | Why? |
| Hemorrhagic Fever, Ebola | 3 | 2019 | 1475 | 0.72 | Why? |
| Encephalitis, Japanese | 1 | 2017 | 58 | 0.64 | Why? |
| Yellow fever virus | 5 | 2018 | 205 | 0.64 | Why? |
| Ebolavirus | 3 | 2019 | 834 | 0.63 | Why? |
| Senegal | 8 | 2020 | 283 | 0.46 | Why? |
| Genetic Variation | 4 | 2019 | 3919 | 0.45 | Why? |
| Mobile Health Units | 1 | 2018 | 741 | 0.44 | Why? |
| Chikungunya virus | 3 | 2018 | 339 | 0.42 | Why? |
| Africa, Western | 3 | 2018 | 363 | 0.37 | Why? |
| Flavivirus Infections | 2 | 2019 | 81 | 0.37 | Why? |
| Monkeypox virus | 2 | 2018 | 43 | 0.36 | Why? |
| Monkeypox | 2 | 2018 | 40 | 0.36 | Why? |
| Aedes | 4 | 2019 | 380 | 0.34 | Why? |
| Flavivirus | 2 | 2019 | 182 | 0.33 | Why? |
| Dengue Virus | 3 | 2018 | 910 | 0.32 | Why? |
| Laboratories | 1 | 2018 | 2858 | 0.30 | Why? |
| Point-of-Care Systems | 1 | 2018 | 2955 | 0.28 | Why? |
| Phylogeny | 6 | 2018 | 13341 | 0.28 | Why? |
| Zika Virus | 5 | 2018 | 1924 | 0.26 | Why? |
| Disease Outbreaks | 8 | 2020 | 27595 | 0.23 | Why? |
| Angola | 2 | 2017 | 75 | 0.21 | Why? |
| Zika Virus Infection | 3 | 2018 | 1920 | 0.21 | Why? |
| Recombinases | 1 | 2021 | 137 | 0.20 | Why? |
| Nucleic Acid Amplification Techniques | 3 | 2018 | 3388 | 0.20 | Why? |
| Malaria | 2 | 2020 | 1097 | 0.20 | Why? |
| Culex | 1 | 2019 | 66 | 0.19 | Why? |
| Animal Distribution | 1 | 2018 | 23 | 0.19 | Why? |
| Arthropods | 1 | 2017 | 27 | 0.18 | Why? |
| Arbovirus Infections | 1 | 2019 | 104 | 0.18 | Why? |
| Mosquito Vectors | 2 | 2018 | 351 | 0.18 | Why? |
| Ebola Vaccines | 1 | 2019 | 126 | 0.17 | Why? |
| Biological Variation, Population | 1 | 2017 | 69 | 0.17 | Why? |
| NLR Proteins | 1 | 2017 | 23 | 0.17 | Why? |
| Antibodies, Protozoan | 1 | 2017 | 121 | 0.17 | Why? |
| Molecular Typing | 1 | 2018 | 280 | 0.17 | Why? |
| Nanopores | 1 | 2018 | 128 | 0.17 | Why? |
| Guinea | 1 | 2017 | 228 | 0.16 | Why? |
| Codon | 1 | 2018 | 287 | 0.16 | Why? |
| Encephalitis Virus, Japanese | 1 | 2017 | 63 | 0.16 | Why? |
| Plasmodium vivax | 1 | 2017 | 154 | 0.16 | Why? |
| Plasmodium falciparum | 2 | 2017 | 337 | 0.16 | Why? |
| Rabies virus | 1 | 2017 | 92 | 0.16 | Why? |
| Malaria, Vivax | 1 | 2017 | 152 | 0.16 | Why? |
| Genomics | 2 | 2019 | 3118 | 0.16 | Why? |
| Endemic Diseases | 1 | 2020 | 480 | 0.15 | Why? |
| Malaria, Falciparum | 2 | 2017 | 377 | 0.15 | Why? |
| Rabies | 1 | 2017 | 113 | 0.15 | Why? |
| Dengue | 2 | 2018 | 1565 | 0.15 | Why? |
| Encephalitis Viruses, Japanese | 1 | 2014 | 8 | 0.14 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2021 | 11367 | 0.14 | Why? |
| West Nile Fever | 1 | 2017 | 166 | 0.14 | Why? |
| Primates | 1 | 2017 | 584 | 0.14 | Why? |
| Polyproteins | 1 | 2017 | 814 | 0.14 | Why? |
| DEAD Box Protein 58 | 1 | 2017 | 250 | 0.14 | Why? |
| Astrocytes | 1 | 2017 | 298 | 0.14 | Why? |
| Genome, Viral | 5 | 2019 | 13157 | 0.13 | Why? |
| Toll-Like Receptors | 1 | 2017 | 365 | 0.13 | Why? |
| Chikungunya Fever | 1 | 2018 | 345 | 0.13 | Why? |
| Virulence | 2 | 2017 | 2172 | 0.13 | Why? |
| Population Density | 1 | 2018 | 694 | 0.12 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.12 | Why? |
| Sequence Analysis, DNA | 2 | 2017 | 2830 | 0.11 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Africa | 4 | 2019 | 2986 | 0.09 | Why? |
| Temperature | 1 | 2018 | 2305 | 0.09 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.09 | Why? |
| Coinfection | 2 | 2019 | 6820 | 0.09 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.09 | Why? |
| World Health Organization | 2 | 2020 | 4213 | 0.09 | Why? |
| Patient Isolation | 2 | 2020 | 3182 | 0.08 | Why? |
| Host-Pathogen Interactions | 2 | 2017 | 11041 | 0.08 | Why? |
| Democratic Republic of the Congo | 2 | 2019 | 500 | 0.08 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.08 | Why? |
| Enzyme-Linked Immunosorbent Assay | 5 | 2020 | 7868 | 0.08 | Why? |
| RNA, Viral | 6 | 2020 | 32276 | 0.08 | Why? |
| Animals | 11 | 2019 | 78931 | 0.08 | Why? |
| Cell Line | 2 | 2019 | 12040 | 0.07 | Why? |
| Smartphone | 1 | 2017 | 1840 | 0.07 | Why? |
| Antibodies, Viral | 6 | 2020 | 51949 | 0.07 | Why? |
| Communicable Diseases | 1 | 2020 | 2148 | 0.07 | Why? |
| Poverty | 1 | 2017 | 2302 | 0.07 | Why? |
| Travel | 3 | 2020 | 7220 | 0.07 | Why? |
| Evolution, Molecular | 1 | 2018 | 3691 | 0.07 | Why? |
| Zoonoses | 1 | 2018 | 3034 | 0.07 | Why? |
| Contact Tracing | 3 | 2020 | 8448 | 0.07 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.07 | Why? |
| DNA Primers | 2 | 2018 | 1170 | 0.06 | Why? |
| Humans | 32 | 2021 | 930598 | 0.06 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 13720 | 0.06 | Why? |
| Ethiopia | 2 | 2018 | 1222 | 0.06 | Why? |
| Mice | 3 | 2017 | 21357 | 0.06 | Why? |
| Electrocardiography | 1 | 2017 | 3957 | 0.06 | Why? |
| Young Adult | 6 | 2020 | 93724 | 0.06 | Why? |
| Virus Replication | 3 | 2019 | 14331 | 0.06 | Why? |
| Immunoglobulin G | 3 | 2020 | 21571 | 0.06 | Why? |
| Viral Envelope Proteins | 1 | 2014 | 3539 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Naphthyridines | 1 | 2020 | 48 | 0.05 | Why? |
| Nigeria | 2 | 2018 | 2292 | 0.05 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.05 | Why? |
| Aneurysm, Infected | 1 | 2020 | 36 | 0.05 | Why? |
| Viral Nonstructural Proteins | 1 | 2018 | 4810 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2019 | 8041 | 0.05 | Why? |
| Plasmodium | 1 | 2019 | 74 | 0.05 | Why? |
| Models, Statistical | 1 | 2016 | 5312 | 0.05 | Why? |
| Viral Proteins | 1 | 2017 | 7370 | 0.05 | Why? |
| Animals, Newborn | 1 | 2019 | 350 | 0.05 | Why? |
| Sudan | 1 | 2018 | 166 | 0.05 | Why? |
| Financial Support | 1 | 2020 | 170 | 0.05 | Why? |
| Asymptomatic Infections | 1 | 2017 | 7218 | 0.05 | Why? |
| Biostatistics | 1 | 2019 | 116 | 0.05 | Why? |
| Artemisinins | 1 | 2020 | 238 | 0.05 | Why? |
| DNA, Protozoan | 1 | 2017 | 77 | 0.04 | Why? |
| Merozoite Surface Protein 1 | 1 | 2017 | 8 | 0.04 | Why? |
| Disease Vectors | 1 | 2019 | 208 | 0.04 | Why? |
| Gene Library | 1 | 2018 | 234 | 0.04 | Why? |
| Tanzania | 1 | 2018 | 294 | 0.04 | Why? |
| Haplorhini | 1 | 2018 | 307 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Male | 10 | 2020 | 367725 | 0.04 | Why? |
| Adaptation, Biological | 1 | 2018 | 179 | 0.04 | Why? |
| Antigens, Viral | 1 | 2014 | 6298 | 0.04 | Why? |
| Antigens, Protozoan | 1 | 2017 | 121 | 0.04 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.04 | Why? |
| Yellow Fever Vaccine | 1 | 2018 | 198 | 0.04 | Why? |
| Culicidae | 1 | 2018 | 239 | 0.04 | Why? |
| Insect Vectors | 1 | 2018 | 227 | 0.04 | Why? |
| Protozoan Proteins | 1 | 2017 | 205 | 0.04 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2017 | 501 | 0.04 | Why? |
| Child | 6 | 2020 | 70012 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Reverse Transcription | 1 | 2018 | 673 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Child, Preschool | 4 | 2020 | 36283 | 0.03 | Why? |
| Epidemics | 3 | 2020 | 6407 | 0.03 | Why? |
| Neutralization Tests | 2 | 2018 | 6698 | 0.03 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Sequence Homology | 1 | 2014 | 448 | 0.03 | Why? |
| Receptors, Immunologic | 1 | 2017 | 555 | 0.03 | Why? |
| Malaysia | 1 | 2017 | 1116 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2020 | 9091 | 0.03 | Why? |
| Polymerase Chain Reaction | 2 | 2017 | 6740 | 0.03 | Why? |
| Metagenomics | 1 | 2018 | 823 | 0.03 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.03 | Why? |
| Specimen Handling | 2 | 2020 | 6190 | 0.03 | Why? |
| Kinetics | 1 | 2019 | 3238 | 0.03 | Why? |
| Asia | 1 | 2018 | 2399 | 0.03 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.03 | Why? |
| RNA Viruses | 1 | 2018 | 824 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Spatio-Temporal Analysis | 1 | 2017 | 1182 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2018 | 1439 | 0.02 | Why? |
| Immunization Schedule | 1 | 2016 | 1305 | 0.02 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.02 | Why? |
| Female | 9 | 2020 | 380317 | 0.02 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.02 | Why? |
| Exanthema | 1 | 2018 | 1097 | 0.02 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.02 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.02 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.02 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.02 | Why? |
| Adult | 6 | 2020 | 244371 | 0.02 | Why? |
| Urban Population | 1 | 2016 | 2000 | 0.02 | Why? |
| Middle Aged | 6 | 2020 | 270681 | 0.02 | Why? |
| Aged | 5 | 2020 | 215776 | 0.02 | Why? |
| Telemedicine | 1 | 2017 | 25032 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Computer Simulation | 1 | 2019 | 4982 | 0.02 | Why? |
| Logistic Models | 1 | 2019 | 9089 | 0.02 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.02 | Why? |
| Rural Population | 1 | 2016 | 2408 | 0.02 | Why? |
| Developing Countries | 1 | 2020 | 4283 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.02 | Why? |
| Serologic Tests | 1 | 2017 | 4359 | 0.02 | Why? |
| Vero Cells | 1 | 2019 | 14117 | 0.02 | Why? |
| Cross Reactions | 1 | 2014 | 4374 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2018 | 10017 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
| Vaccination | 2 | 2017 | 19050 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.01 | Why? |
| Brazil | 1 | 2018 | 12582 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.01 | Why? |
| Retrospective Studies | 2 | 2019 | 105322 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Public Health | 1 | 2018 | 16359 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2014 | 25288 | 0.01 | Why? |